- Ribonucleotide Reductase Subunit M2 Can Be New Molecular Target and Prognostic Biomarker of Hepatocellular Carcinoma
-
Kim HY, Kim CW
- KMID: 2070072
- Gut Liver.
- 2014 Nov;8(6):580-581.
- doi: 10.5009/gnl14377
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Application of Hemin-Agarose Affinity Chromatography to Enrich Proteome Components of Helicobacter pylori Strain 26695
-
Kang HL, Baik SC
- KMID: 1574111
- J Bacteriol Virol.
- 2005 Jun;35(2):77-85.
The whole cell extract of Helicobacter pylori strain 26695 was treated with the hemin-agarose resin and the bound fraction was analyzed by 2-Dimensional electrophoresis. The 2-D-PAGE-displayed spots were eluted and... -
- CITED
-
- Close
- SHARE
-
- Close
- High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
-
Lee B, Ha SY, Song DH, Lee HW, Cho SY, Park CK
- KMID: 2070085
- Gut Liver.
- 2014 Nov;8(6):662-668.
- doi: 10.5009/gnl13392
BACKGROUND/AIMS: Ribonucleotide reductase subunit M2 (RRM2) catalyzes the production of deoxynucleotide triphosphates, which are necessary for DNA synthesis. RRM2 has been reported to play an active role in tumor progression,... -
- CITED
-
- Close
- SHARE
-
- Close
- Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2
-
Yun HJ, Cho YH, Moon Y, Park YW, Yoon HK, Kim YJ, Cho SH, Lee YI, Kang BS, Kim WJ, Park K, Seo W
- KMID: 756337
- Exp Mol Med.
- 2008 Jun;40(3):345-353.
- doi: 10.3858/emm.2008.40.3.345
For cancer gene therapy, cancer-specific over-expression of a therapeutic gene is required to reduce side effects derived from expression of the gene in normal cells. To develop such an expression... -
- CITED
-
- Close
- SHARE
-
- Close
